Journal Report

INFLAMMATORY BOWEL DISEASES

Download PDF
Journal Information
Journal Title
INFLAMMATORY BOWEL DISEASES
Publisher
OXFORD UNIV PRESS INC
ISSN
1078-0998
E-ISSN
1536-4844
Database
Clarivate
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
From genotype-level dysfunction to variant-level causality in SLC10A2-associated bile acid malabsorption
Ercan Yılmaz, Zeynep Yamancan Yılmaz
2026-10-30
DOI: 10.1093/ibd/izag231
Handheld intestinal ultrasound and the point-of-care questions in pediatric IBD: a commentary—authors’ reply
Yusuke Miyatani, Alexandra Hudson, Joëlle St-Pierre et al.
2026-10-30
DOI: 10.1093/ibd/izag199
Fecal calprotectin testing for inflammatory bowel disease in patients presenting with lower gastrointestinal symptoms: a retrospective primary care cohort study in the United Kingdom
Nosheen Umar, Steven Wambua, Phil Harvey et al.
2026-10-29
DOI: 10.1093/ibd/izag218
Comparing real-world continuous clinical remission rates of anti-tumor necrosis factor, vedolizumab, ustekinumab, tofacitinib, and upadacitinib in ulcerative colitis
Andrea Cassinotti, Simone Saibeni, Rosanna Cannatelli et al.
2026-10-29
DOI: 10.1093/ibd/izag229
Comparison of risankizumab and upadacitinib treatment persistence according to disease location in patients with Crohn’s disease: data from the CREdIT registry
Ondrej Hradsky, Dana Duricova, Milan Lukas et al.
2026-10-28
DOI: 10.1093/ibd/izag224
Hyperuricemia aggravates acute colitis through NLRP3-associated macrophage-lineage inflammatory responses
Junyi Ji, Yize Wang, Tianyu Zhou et al.
2026-10-27
DOI: 10.1093/ibd/izag227
Risk of serious infection, myocardial infarction, stroke, and thromboembolic events in patients in the United States with ulcerative colitis treated with tofacitinib compared with biologic treatments
Xiang Ma, Qingqing Shan
2026-10-26
DOI: 10.1093/ibd/izag226
Fecal microbiota transplant in the treatment of inflammatory bowel diseases: new perspectives on delivery, mechanism, and clinical positioning
Anum Javed, Despoina Chrysostomou, Julian R Marchesi et al.
2026-10-24
DOI: 10.1093/ibd/izag219
Reply to “Risk of serious infection, myocardial infarction, stroke, and thromboembolic events in patients in the United States with ulcerative colitis treated with tofacitinib compared with biologic treatments”
Milena A Gianfrancesco, Jeffrey R Curtis
2026-10-24
DOI: 10.1093/ibd/izag220
Isolated perianal Crohn disease: the next challenge is long-term surveillance
Deloshaan Subhaharan
2026-10-21
DOI: 10.1093/ibd/izag209
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: October 31, 2026 12:52